$500K being shifted around to help P.E.I. agricultural sector respond to U.S. tariffs
The P.E.I. Department of Agriculture and the Government of Canada have announced they are redirecting $500,000 to help the provincial agriculture sector in response to the tariffs imposed by U.S. President Donald Trump.
These funds will flow into three programs falling under the Sustainable Canadian Agricultural Partnership programming. That's a five-year, $3.5 billion plan to help farmers, operators and producers across the country.
According to a news release, it aims to "strengthen the competitiveness, innovation, and resiliency of Canada's agriculture, agri‐food, and agri‐based products sector."
The Product and Market Development Program is designed to expand domestic and international competitiveness for small and medium-sized agricultural producers.
The Strategic Industry Growth Initiative is meant to help the agriculture sector speed up the commercialization of food products.
The Business Development Program provides training on things like business planning and implementation, organizational development, and risk activities.
The news release says the P.E.I. Department of Agriculture will assess the applications. It will also work with the P.E.I. Department of Economic Development, Innovation and Trade to support agricultural initiatives.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Forbes
21 minutes ago
- Forbes
U.S.-China Trade Deal ‘Done,' Trump Says
President Donald Trump on Wednesday said a trade agreement was reached between the U.S. and China, pending final approval from him and Chinese President Xi Jinping, following weeks of escalated tensions between both countries as trade negotiations were carried out. The trade agreement includes full magnets and 'any necessary rare earths' from China as the U.S. ... More makes concessions on student visas. Trump, in a post on Truth Social, said a deal was 'done' between the U.S. and China, which will supply 'any necessary rare earths' and full magnets as the U.S. makes concessions on allowing Chinese students to attend American universities. This is a developing story.
Yahoo
22 minutes ago
- Yahoo
2 Cash-Producing Stocks to Research Further and 1 to Avoid
While strong cash flow is a key indicator of stability, it doesn't always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning. Not all companies are created equal, and StockStory is here to surface the ones with real upside. That said, here are two cash-producing companies that leverage their financial strength to beat the competition and one that may struggle to keep up. Trailing 12-Month Free Cash Flow Margin: 37.1% Founded in 2007 as DiscoveryOrg and renamed after a merger in 2019, ZoomInfo (NASDAQ:ZI) is a software as a service product that provides sales departments with access to a database of prospective clients. Why Do We Avoid ZI? Flat billings over the last year suggest it may need to improve its products, pricing, or go-to-market strategy to reinvigorate demand Complex implementation process for enterprise clients means customers take longer to ramp up, as seen in its extended payback periods Day-to-day expenses have swelled relative to revenue over the last year as its operating margin fell by 10.3 percentage points ZoomInfo's stock price of $10.28 implies a valuation ratio of 2.9x forward price-to-sales. Dive into our free research report to see why there are better opportunities than ZI. Trailing 12-Month Free Cash Flow Margin: 10.6% Started by Oleg Shchegolev while still in university, Semrush (NYSE:SEMR) is a software-as-a-service platform that helps companies optimize their search engine and content marketing efforts. Why Are We Positive On SEMR? Average billings growth of 24.8% over the last year enhances its liquidity and shows there is steady demand for its products Sales outlook for the upcoming 12 months implies the business will stay on its desirable three-year growth trajectory Software is difficult to replicate at scale and results in a stellar gross margin of 82.1% At $10.19 per share, Semrush trades at 3.3x forward price-to-sales. Is now a good time to buy? Find out in our full research report, it's free. Trailing 12-Month Free Cash Flow Margin: 2.5% With an emphasis on ethically produced products, Vital Farms (NASDAQ:VITL) specializes in pasture-raised eggs and butter. Why Is VITL a Top Pick? Products are flying off the shelves as its unit sales averaged 17.8% growth over the past two years Expected revenue growth of 26.6% for the next year suggests its market share will rise Earnings per share grew by 161% annually over the last three years and trumped its peers Vital Farms is trading at $33 per share, or 23.8x forward P/E. Is now the right time to buy? See for yourself in our in-depth research report, it's free. The market surged in 2024 and reached record highs after Donald Trump's presidential victory in November, but questions about new economic policies are adding much uncertainty for 2025. While the crowd speculates what might happen next, we're homing in on the companies that can succeed regardless of the political or macroeconomic environment. Put yourself in the driver's seat and build a durable portfolio by checking out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025). Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today for free. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
22 minutes ago
- Yahoo
2 Growth Stocks to Stash and 1 to Question
Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market's punishment can be swift and severe when trajectories fall. Deciphering which businesses can sustain their high growth rates is a challenge for even the most seasoned professionals, which is why we started StockStory. On that note, here are two growth stocks expanding their competitive advantages and one climbing an uphill battle. One-Year Revenue Growth: +25.3% Founded in 2009 by enterprise software veteran Tom Seibel, (NYSE:AI) provides software that makes it easy for organizations to add artificial intelligence technology to their applications. Why Does AI Fall Short? 15.5% annual revenue growth over the last three years was slower than its software peers Extended payback periods on sales investments suggest the company's platform isn't resonating enough to drive efficient sales conversions Historical operating margin losses point to an inefficient cost structure stock price of $25.72 implies a valuation ratio of 7.4x forward price-to-sales. Dive into our free research report to see why there are better opportunities than AI. One-Year Revenue Growth: +32.3% Founded in 2014 and named after the dreaded first day of the work week, (NASDAQ:MNDY) is a software-as-a-service platform that helps organizations plan and track work efficiently. Why Is MNDY a Good Business? ARR trends over the last year show it's maintaining a steady flow of long-term contracts that contribute positively to its revenue predictability Software is difficult to replicate at scale and results in a best-in-class gross margin of 89.5% Strong free cash flow margin of 30.4% enables it to reinvest or return capital consistently is trading at $305 per share, or 12.7x forward price-to-sales. Is now a good time to buy? Find out in our full research report, it's free. One-Year Revenue Growth: +20% Founded in 2010 and named for a combination of 'docs' and 'proximity', Doximity (NYSE: DOCS) is the leading social network for U.S. medical professionals. Why Should DOCS Be on Your Watchlist? Billings have averaged 23.5% growth over the last year, showing it's securing new contracts that could potentially increase in value over time Well-designed software integrates seamlessly with other workflows, enabling swift payback periods on marketing expenses and customer growth at scale DOCS is a free cash flow machine with the flexibility to invest in growth initiatives or return capital to shareholders At $58.44 per share, Doximity trades at 19x forward price-to-sales. Is now the right time to buy? See for yourself in our comprehensive research report, it's free. Market indices reached historic highs following Donald Trump's presidential victory in November 2024, but the outlook for 2025 is clouded by new trade policies that could impact business confidence and growth. While this has caused many investors to adopt a "fearful" wait-and-see approach, we're leaning into our best ideas that can grow regardless of the political or macroeconomic climate. Take advantage of Mr. Market by checking out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025). Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today for free.
